JP2019531261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019531261A5 JP2019531261A5 JP2019503956A JP2019503956A JP2019531261A5 JP 2019531261 A5 JP2019531261 A5 JP 2019531261A5 JP 2019503956 A JP2019503956 A JP 2019503956A JP 2019503956 A JP2019503956 A JP 2019503956A JP 2019531261 A5 JP2019531261 A5 JP 2019531261A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- subject
- level
- biological sample
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(*(C)(C)C)C(*(CCC1)C1C(O)=O)=O Chemical compound CC(*(C)(C)C)C(*(CCC1)C1C(O)=O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662367839P | 2016-07-28 | 2016-07-28 | |
| US62/367,839 | 2016-07-28 | ||
| PCT/US2017/044151 WO2018022866A1 (en) | 2016-07-28 | 2017-07-27 | Diagnostic methods, therapeutic agents and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019531261A JP2019531261A (ja) | 2019-10-31 |
| JP2019531261A5 true JP2019531261A5 (https=) | 2020-09-03 |
| JP6987123B2 JP6987123B2 (ja) | 2021-12-22 |
Family
ID=59579921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019503956A Active JP6987123B2 (ja) | 2016-07-28 | 2017-07-27 | 化合物、試薬およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10865183B2 (https=) |
| EP (1) | EP3491004B1 (https=) |
| JP (1) | JP6987123B2 (https=) |
| CN (1) | CN109563127B (https=) |
| AU (1) | AU2017301949B2 (https=) |
| CA (1) | CA3032116A1 (https=) |
| ES (1) | ES2891088T3 (https=) |
| WO (1) | WO2018022866A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3184836A1 (en) * | 2013-05-14 | 2014-11-20 | Metabolon, Inc. | Biomarkers related to kidney function and methods using the same |
| US11182920B2 (en) * | 2018-04-26 | 2021-11-23 | Jerry NAM | Automated determination of muscle mass from images |
| TWI669506B (zh) * | 2018-07-06 | 2019-08-21 | 國軍桃園總醫院 | 計算腎絲球過濾率之方法 |
| US12553902B2 (en) * | 2019-12-16 | 2026-02-17 | Hill's Pet Nutrition, Inc. | Methods, kits and compositions for diagnosing and treating renal disease |
| CN114026427B (zh) * | 2020-05-19 | 2023-11-17 | 深圳市中医院 | 诊断肾病的标志物以及诊断方法 |
| WO2022125056A1 (en) | 2020-12-07 | 2022-06-16 | Kimberly-Clark Worldwide, Inc. | Methods and consumer products for detecting a metabolite |
| CN119355249A (zh) * | 2024-09-20 | 2025-01-24 | 长沙都正生物科技股份有限公司 | 苯乙酰谷氨酰胺及其与氧化三甲胺联用作为糖尿病肾病诊断标志物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3184836A1 (en) | 2013-05-14 | 2014-11-20 | Metabolon, Inc. | Biomarkers related to kidney function and methods using the same |
| US10393749B2 (en) * | 2013-12-11 | 2019-08-27 | Shiseido Company, Ltd. | Marker for early diagnosis of kidney failure |
-
2017
- 2017-07-27 AU AU2017301949A patent/AU2017301949B2/en active Active
- 2017-07-27 EP EP17751177.1A patent/EP3491004B1/en active Active
- 2017-07-27 CN CN201780046847.5A patent/CN109563127B/zh active Active
- 2017-07-27 WO PCT/US2017/044151 patent/WO2018022866A1/en not_active Ceased
- 2017-07-27 US US16/321,135 patent/US10865183B2/en active Active
- 2017-07-27 JP JP2019503956A patent/JP6987123B2/ja active Active
- 2017-07-27 CA CA3032116A patent/CA3032116A1/en active Pending
- 2017-07-27 ES ES17751177T patent/ES2891088T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531261A5 (https=) | ||
| JP2016520192A5 (https=) | ||
| Leem et al. | Value of serum cystatin C measurement in the diagnosis of sepsis-induced kidney injury and prediction of renal function recovery | |
| Hokamp et al. | Renal biomarkers in domestic species | |
| JP2020112568A (ja) | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 | |
| AU2014265669B2 (en) | Biomarkers related to kidney function and methods using the same | |
| EA201290711A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| RU2009139295A (ru) | Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек | |
| RU2020134037A (ru) | Способы скрининга субъекта на риск развития хронической болезни почек и компьютерно-реализуемый способ | |
| JP2017078719A (ja) | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 | |
| BR112014006741A2 (pt) | método para monitorização, diagnóstico e/ou prognóstico de lesão renal aguda no estágio inicial | |
| JP6185035B2 (ja) | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 | |
| JP7109441B2 (ja) | 神経変性疾患を判定するための診断補助方法 | |
| JP6186400B2 (ja) | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 | |
| JP2018529931A5 (https=) | ||
| JP2016180762A (ja) | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 | |
| EA201290056A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| ES2690486T3 (es) | Biomarcador de enfermedad renal crónica | |
| WO2014140974A3 (en) | System and method for determining risk of diabetes based on biochemical marker analysis | |
| CY1119797T1 (el) | Λακτοφερινη για χρηση στη διαγνωση και προγνωση της νοσου alzheimer | |
| JP2016532115A5 (https=) | ||
| JP2021523375A5 (https=) | ||
| Gentilini et al. | Validation of a human immunoturbidimetric assay to measure canine albumin in urine and cerebrospinal fluid | |
| CN107589260A (zh) | 尿液中mmp-7作为肾脏纤维化和慢性肾脏病的生物标志物的用途 | |
| JP2015528562A5 (https=) |